Nature Journal
Feb 08, 2017
Clinical trials need to assess drug efficacy before trials
On 17 January 2016, a healthy man was declared brain-dead after receiving an experimental drug in a first-in-human trial in France. Four of five other subjects receiving the same dose have serious, ongoing neurological complications. Investigations into the trial described many troubling safety practices, such as st...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
